Concepedia

BenevolentAI (United Kingdom)

B(

Statistics

Publications

165

Citations

41.4K

Authors

7

Location

London, United Kingdom

BenevolentAI (United Kingdom) is a company institution in London, United Kingdom known for drug discovery, pharmacology, and bioinformatics.

HomepageWikipediaROR

Top concepts

Publications

165

Planning chemical syntheses with deep neural networks and symbolic AI

Marwin Segler, Mark P. Waller · Nature · 2018 · 1.9K citations · Full text

, , +16

The druggable genome and support for target identification and validation in drug development

Chris Finan, Anna Gaulton, Felix Krüger et al. · Science Translational Medicine · 2017 · 1K citations

, , +17

GuacaMol: Benchmarking Models for de Novo Molecular Design

Journal of Chemical Information and Modeling · 2019 · 772 citations · Full text

, , +12

Pharos: Collating protein information to shed light on the druggable genome

Ðắc-Trung Nguyễn, Stephen L. Mathias, Cristian Bologa et al. · Nucleic Acids Research · 2016 · 318 citations · Full text

, , +15

Improving the odds of drug development success through human genomics: modelling study

Aroon D. Hingorani, Valerie Kuan, Chris Finan et al. · Scientific Reports · 2019 · 272 citations · Full text

, , +12

1–5 of 165

Authors

7

  1. OO
    Olly Oechsle

    BenevolentAI (United Kingdom), United Kingdom

    5 publications · 2.7K citations

    4

    h-index

  2. MA
    Matthew A Sellwood

    BenevolentAI (United Kingdom), United Kingdom

    4 publications · 316 citations

    3

    h-index

  3. BF
    Benedek Fabian

    BenevolentAI (United Kingdom), United Kingdom

    5 publications · 426 citations

    3

    h-index

  4. MF
    Marco Fiscato

    BenevolentAI (United Kingdom), United Kingdom

    8 publications · 119 citations

    2

    h-index

  5. DP
    Dean Plumbley

    BenevolentAI (United Kingdom), United Kingdom

    3 publications · 144 citations

    2

    h-index

1–5 of 7